Poon D - Search Results

1

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma.

Leong SS, Wee J, Rajan S, Toh CK, Lim WT, Hee SW, Tay MH, Poon D, Tan EH. Leong SS, et al. Among authors: poon d. Cancer. 2008 Sep 15;113(6):1332-7. doi: 10.1002/cncr.23687. Cancer. 2008. PMID: 18615622 Free article.

2

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma.

Chia WK, Ong S, Toh HC, Hee SW, Choo SP, Poon DY, Tay MH, Tan CK, Koo WH, Foo KF. Chia WK, et al. Ann Acad Med Singap. 2008 Jul;37(7):554-8. Ann Acad Med Singap. 2008. PMID: 18695766 Free article. Clinical Trial.

3

A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly.

Leong SS, Toh CK, Lim WT, Lin X, Tan SB, Poon D, Tay MH, Foo KF, Ho J, Tan EH. Leong SS, et al. Among authors: poon d. J Thorac Oncol. 2007 Mar;2(3):230-6. doi: 10.1097/JTO.0b013e318031d06f. J Thorac Oncol. 2007. PMID: 17410046 Free article. Clinical Trial.

4

Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status.

Ngeow J, Leong SS, Gao F, Toh CK, Lim WT, Tan EH, Poon D. Ngeow J, et al. Among authors: poon d. Crit Rev Oncol Hematol. 2010 Oct;76(1):53-60. doi: 10.1016/j.critrevonc.2009.10.005. Epub 2009 Nov 24. Crit Rev Oncol Hematol. 2010. PMID: 19939700

5

Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.

Poon D, Yap SP, Wong ZW, Cheung YB, Leong SS, Wee J, Tan T, Fong KW, Chua ET, Tan EH. Poon D, et al. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1312-8. doi: 10.1016/j.ijrobp.2004.01.037. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275714

6

Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma.

Poon D, Chowbay B, Cheung YB, Leong SS, Tan EH. Poon D, et al. Cancer. 2005 Feb 1;103(3):576-81. doi: 10.1002/cncr.20802. Cancer. 2005. PMID: 15612023 Free article. Clinical Trial.

7

Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma.

Ang SF, Tan SH, Toh HC, Poon DY, Ong SY, Foo KF, Choo SP. Ang SF, et al. Am J Clin Oncol. 2012 Jun;35(3):222-7. doi: 10.1097/COC.0b013e31820dbf56. Am J Clin Oncol. 2012. PMID: 21378539

8

A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma.

Ang MK, Poon D, Foo KF, Chung YF, Chow P, Wan WK, Thng CH, Ooi L. Ang MK, et al. Among authors: poon d. Hematol Oncol Stem Cell Ther. 2008 Jul-Sep;1(3):159-65. doi: 10.1016/s1658-3876(08)50024-0. Hematol Oncol Stem Cell Ther. 2008. PMID: 20063546 Free article. Clinical Trial.

9

Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre.

Farid M, Ong WS, Lee MJ, Jeevan R, Ho ZC, Sairi AN, Soh LT, Poon D, Teh J, Chin F, Teo M, Quek R. Farid M, et al. Among authors: poon d. Oncology. 2013;85(3):182-90. doi: 10.1159/000354215. Epub 2013 Aug 31. Oncology. 2013. PMID: 24008869

10

The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.

Farid M, Ong WS, Tan MH, Foo LS, Lim YK, Chia WK, Soh LT, Poon D, Lee MJ, Ho ZC, Jeevan R, Chin F, Teo M, Quek R. Farid M, et al. Among authors: poon d. Am J Clin Oncol. 2013 Aug;36(4):368-74. doi: 10.1097/COC.0b013e318248dbf4. Am J Clin Oncol. 2013. PMID: 22772425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters